Libai Lu
Overview
Explore the profile of Libai Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan H, Liang W, You S, Zhou J, Chen S, Tan X, et al.
Pancreas
. 2025 Feb;
PMID: 39933051
Objective: To investigate the clinical efficacy of laparoscopic peritoneal lavage and drainage (LPLD) in the early stage of severe acute pancreatitis (SAP) and its potential role in reversing organ failure....
2.
Pan L, Huang H, Zhang P, Li H, Lu L, Wei M, et al.
J Cancer
. 2024 Nov;
15(19):6239-6255.
PMID: 39513103
Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy, with its pathogenesis involving a complex interplay of molecular mechanisms, including cell cycle dysregulation, evasion of apoptosis, enhanced angiogenesis, and aberrant immune...
3.
Wu Y, Zhuo C, Lu Y, Luo Z, Lu L, Wang J, et al.
J Gastrointest Oncol
. 2024 Jul;
15(3):1082-1100.
PMID: 38989413
Background: Hepatocellular carcinoma (HCC) poses a global threat to life; however, numerical tools to predict the clinical prognosis of these patients remain scarce. The primary objective of this study is...
4.
Wei M, Lu L, Luo Z, Ma J, Wang J
BMC Gastroenterol
. 2024 Apr;
24(1):142.
PMID: 38654165
Objectives: Cuproptosis represents an innovative type of cell death, distinct from apoptosis, driven by copper dependency, yet the involvement of copper apoptosis-associated long non-coding RNAs (CRLncRNAs) in hepatocellular carcinoma (HCC)...
5.
Wei M, Lu L, Ma J, Luo Z, Tan X, Wang J
J Cell Mol Med
. 2024 Jan;
28(5):e18106.
PMID: 38239038
Hepatocellular carcinoma (HCC) is the fifth most frequently diagnosed cancer and ranks third in cancer-related fatalities. The recognized involvement of long noncoding RNAs (lncRNAs) in several cancer types, including HCC,...
6.
Lu L, Li S, Zhang Y, Luo Z, Chen Y, Ma J, et al.
Front Oncol
. 2021 Jan;
10:607593.
PMID: 33489916
Hepatocellular carcinoma (HCC) is a common malignant liver tumor worldwide. Tumor recurrence and metastasis contribute to the bad clinical outcome of HCC patients. Substantial studies have displayed lncRNAs modulate various...
7.
Luo Z, Lu L, Tang Q, Wei W, Chen P, Chen Y, et al.
J Cell Mol Med
. 2021 Jan;
25(8):3793-3802.
PMID: 33484498
Hepatocellular carcinoma (HCC) is one of the most common cancers with high prevalence and mortality, and it has brought huge economic and health burden for the world. It is urgent...
8.
Yan F, Fan B, Wang J, Wei W, Tang Q, Lu L, et al.
Cancer Med
. 2021 Jan;
10(3):833-842.
PMID: 33481351
Increasing circRNAs have attracted a lot of attention because of their significant biological effects in many diseases. It has been reported that circ_0008305 can modulate lung cancer progression. However, the...
9.
Identification of Driver Genes Regulating the T-Cell-Infiltrating Levels in Hepatocellular Carcinoma
Cai Y, Tian Y, Wang J, Wei W, Tang Q, Lu L, et al.
Front Genet
. 2020 Dec;
11:560546.
PMID: 33381145
The driver genes regulating T-cell infiltration are important for understanding immune-escape mechanisms and developing more effective immunotherapy. However, researches in this field have rarely been reported in hepatocellular carcinoma (HCC)....
10.
Wang J, Wang W, Tang Q, Lu L, Luo Z, Li W, et al.
Front Genet
. 2020 Nov;
11:1029.
PMID: 33193591
Recent studies have investigated the modulatory roles of long non-coding RNAs in the onset and progression of liver cancer. The present study aimed to elucidate the role of lnc-GNAT1-1 in...